Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Axios on your phone

Get breaking news and scoops on the go with the Axios app.

Download for free.

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios NW Arkansas

Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!
Data: Axios/Ipsos survey; Note: Margin of error for the total sample is ±3.2%; Chart: Axios Visuals

Barely two in 10 Americans would take a first-generation coronavirus vaccine if President Trump told them it was safe — one of several new measures of his sinking credibility in the latest wave of the Axios-Ipsos Coronavirus Index.

Details: Given eight scenarios and asked how likely they were to try the vaccine in each case, respondents said they'd be most inclined if their doctor vouched for its safety (62%), followed by insurance covering the full cost (56%) or the FDA saying it's safe (54%).

  • Acting on Trump's assurances came in dead last as an option (19%).
  • People said they'd be more likely to take it if they had to pay $100 out of pocket or visit a hospital to get it.

The big picture: With just five weeks left in the election, Week 26 of our national survey offers additional signs that trust in the president and his administration are continuing to fall over the handling of the pandemic.

  • Just 32% said they trust the federal government to provide them with accurate information about COVID-19, down four percentage points from a week ago and a new low for the index.
  • Trust in the White House fell to 28%, and trust in Trump himself fell to 27% — also new lows.
  • Trust in Joe Biden is higher, but not exactly a vote of confidence: 47% of respondents said they trust him, consistent with past weeks.

What they're saying: "You don't want to be the least credible on one of the primary issues of the day," said Cliff Young, president of Ipsos U.S. Public Affairs.

  • This week's findings show that people still prioritize science over politics when it comes to putting something in their bodies — but Young said the depths of Trump's measures point to something more.
  • "Not only is he not an expert, but he's undermined his own credibility" in the way that "he's flip-flopped and twisted and spun things when it comes to the science around the virus."

By the numbers: Republicans were the least likely to act on their doctor's word (56%) and the most likely to follow Trump's (40%).

  • Just 9% of Democrats and 15% independents said they'd be likely to take the first-generation vaccine if Trump said it was safe.
  • Just 4% of Black respondents and 16% of Hispanic respondents said they'd act on that cue from Trump, compared with 23% of white respondents.
  • Overall, men were more willing than women to say they'd try a first-generation vaccine.

What we're watching: At least for now, Americans indicate they're willing to put others' needs ahead of their own when it comes to a vaccine — or perhaps they're content to let others serve as a first test.

  • In this week's survey, respondents were asked on a scale of one to seven to rank how important it was for various groups in society to be able to take the first-generation vaccine.
  • They prioritized health care workers, followed by residents of nursing homes or assisted living facilities, people over 65 and teachers.
  • They placed themselves at the bottom of the list in terms of who should get it first, along with people younger than 30.
  • Politicians were toward the bottom on people's rankings of whose access was most important to protect — and led the rankings for whose access should be least important.

Methodology: This Axios/Ipsos Poll was conducted Sept. 24–27 by Ipsos’ KnowledgePanel®. This poll is based on a nationally representative probability sample of 1,075 general population adults age 18 or older.

  • The margin of sampling error is ± 3.2 percentage points at the 95% confidence level.

Go deeper

Severe coronavirus infections continue to mount

Expand chart
Data: The COVID Tracking ProjectHarvard Global Health Institute; Cartogram: Andrew Witherspoon/Axios

Deaths and severe illness from the coronavirus continue to set new records almost every day, especially in the South and the West.

The big picture: More than 130,000 Americans are in the hospital today with COVID-19 infections. That's straining several states' health care systems and will keep pushing the virus' death toll higher and higher.

Schumer: First priority in new Senate is $2,000 stimulus checks

Senate Minority Leader Chuck Schumer (D-N.Y.) talks with reporters in the Capitol on Jan. 3. Photo: Caroline Brehman/CQ-Roll Call, Inc via Getty Images

Senate Minority Leader Chuck Schumer (D-N.Y.) said Wednesday that one of his first priorities in the 117th Senate will be to pass legislation that would send $2000 stimulus payments.

Why it matters: If Jon Ossoff holds his lead over former Sen. Perdue, Schumer is set to become the next majority leader with the power to steer legislation. The election has not yet been called.

Axios-SurveyMonkey poll: Election fight leaves lasting damage

Data: Axios/SurveyMonkey survey; Chart: Axios Visuals

Nearly 3 in 4 Democrats say the organized effort in Congress to block certification of Joe Biden's Electoral College win is a threat to America's democracy, while 6 in 10 Republicans say it's a defense of it, according to a new SurveyMonkey poll for Axios.

The big picture: The poll shows how badly Biden has been damaged by two months of baseless allegations of election fraud. Just 58% of Americans accept his win as legitimate, while more than one in four doesn't — and most of those skeptics say they won't buy it even if Congress certifies the results today, as expected.

You’ve caught up. Now what?

Sign up for Mike Allen’s daily Axios AM and PM newsletters to get smarter, faster on the news that matters.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!